Review article · 2018 · Open access
Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis
Cell Transplantation, 27(9), 1301–1312 · Published 23 July 2018 · DOI 10.1177/0963689718785154
In brief
“Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis” is a 2018 review article by Jui-Hao Lee and 4 co-authors, published in Cell Transplantation. OpenAlex counts 21 citations as of 18 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Cell Transplantation.
- Citations
- 21
- Most cited in
- 2021 (4)
- Field-weighted impact
- 0.28
- References
- 115
- Authors
- 5
Abstract
Induced pluripotent stem cells (iPSCs), which are generated through reprogramming adult somatic cells by expressing specific transcription factors, can differentiate into derivatives of the three embryonic germ layers and accelerate rapid advances in stem cell research. Neurological diseases such as amyotrophic lateral sclerosis (ALS) have benefited enormously from iPSC technology. This approach can be particularly important for creating iPSCs from patients with familial or sporadic forms of ALS. Motor neurons differentiated from the ALS-patient-derived iPSC can help to determine the relationship between cellular phenotype and genotype. Patient-derived iPSCs facilitate the development of new drugs and/or drug screening for ALS treatment and allow the exploration of the possible mechanism of ALS disease. In this article, we reviewed ALS-patient-specific iPSCs with various genetic mutations, progress in drug development for ALS disease, functional assays showing the differentiation of iPSCs into mature motor neurons, and promising biomarkers in ALS patients for the evaluation of drug candidates.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lee, J.-H., Liu, J.-W., Lin, S., Harn, H., & Chiou, T. (2018). Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis. Cell Transplantation, 27(9), 1301–1312. https://doi.org/10.1177/0963689718785154
MLA 9
Lee, Jui-Hao, et al. “Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.” Cell Transplantation, vol. 27, no. 9, 2018, pp. 1301–1312. https://doi.org/10.1177/0963689718785154.
Chicago
Lee, Jui-Hao, Jen-Wei Liu, Shinn‐Zong Lin, Horng‐Jyh Harn, and Tzyy‐Wen Chiou. 2018. “Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.” Cell Transplantation 27 (9): 1301–1312. https://doi.org/10.1177/0963689718785154.
Harvard
Lee, J.-H. et al. (2018) ‘Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis’, Cell Transplantation, 27(9), pp. 1301–1312. doi:10.1177/0963689718785154.
IEEE
J.-H. Lee, J.-W. Liu, S. Lin, H. Harn, and T. Chiou, “Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis,” Cell Transplantation, vol. 27, no. 9, pp. 1301–1312, 2018, doi: 10.1177/0963689718785154.
BibTeX
@article{lee2018advances,
title = {{Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis}},
author = {Lee, Jui-Hao and Liu, Jen-Wei and Lin, Shinn‐Zong and Harn, Horng‐Jyh and Chiou, Tzyy‐Wen},
journal = {Cell Transplantation},
year = {2018},
volume = {27},
number = {9},
pages = {1301--1312},
doi = {10.1177/0963689718785154},
url = {https://doi.org/10.1177/0963689718785154}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 2 | |
| 2019 | 3 | |
| 2020 | 3 | |
| 2021 | 4 | |
| 2022 | 4 | |
| 2023 | 3 | |
| 2025 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.28: it has been cited 0.28 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- induced pluripotent stem cells
- amyotrophic lateral sclerosis
- patient-derived iPSCs
- motor neuron differentiation
- drug discovery
- drug screening
- iPSC-derived motor neurons
- genetic mutations
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Lee, J.-H., Liu, J.-W., Lin, S., Harn, H., & Chiou, T. (2018). Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis. Cell Transplantation, 27(9), 1301–1312. https://doi.org/10.1177/0963689718785154
How many times has this paper been cited?
21 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cell Transplantation: sign in and open the full text from this page.
Who wrote this paper?
Jui-Hao Lee, Jen-Wei Liu, Shinn‐Zong Lin, Horng‐Jyh Harn, Tzyy‐Wen Chiou.
What is the DOI of this paper?
10.1177/0963689718785154, permanently at https://doi.org/10.1177/0963689718785154. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.